The Evidence Speaks (March 2022)
In recognition of Kidney Month, this edition features research on COVID vaccines and dialysis patients, self-management of glomerular disease, and sleep apnea's impact on CKD progression
Read MoreIn recognition of Kidney Month, this edition features research on COVID vaccines and dialysis patients, self-management of glomerular disease, and sleep apnea's impact on CKD progression
Read MoreCHÉOS Scientists are leading nine of the projects funded in this round, plus a further seven projects are supported by CHÉOS Scientists as co-investigators
Read MoreThis edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read MoreThe 31st edition summarizes some of the latest research from CHÉOS Scientists, including epinephrine and out-of-hospital cardiac arrest, kidney disease treatment, and barriers to post-procedure cardiac care.
Read MoreDrs. Sarah Munro, Joseph Puyat, and Wei Zhang received funding from the Michael Smith Foundation for Health Research this week
Read MoreThe 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read MoreRead about the Scientists and research that appeared in the media over the month.
Read MoreSeveral CHÉOS Scientists will be front and centre at this year's BC Kidney Days event, taking place on November 1.
Read MoreDrs. Anne Gadermann, Ehsan Karim, and Skye Barbic were recently announced as 2018 MSFHR Scholars
Read MoreThe twelfth installment in our series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read More